In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase

被引:21
作者
Cuzon, Gaelle [1 ,3 ]
Naas, Thierry [1 ,3 ]
Guibert, Michele [2 ,3 ]
Nordmann, Patrice [1 ,3 ]
机构
[1] Hop Bicetre, Serv Bacteriol Virol, INSERM, Emerging Resistance Antibiot U914, F-94275 Le Kremlin Bicetre, France
[2] Hop Antoine Beclere, Serv Bacteriol Virol, F-92140 Clamart, France
[3] AP HP, Fac Med Paris Sud, Paris, France
关键词
ESBL; AmpC; Multidrug resistance; Carbapenem resistance; Outer membrane proteins; OMPs; Antimicrobial resistance mechanisms; Carbapenems; CARBAPENEM RESISTANCE; ERTAPENEM RESISTANCE; ESCHERICHIA-COLI; CLINICAL ISOLATE; ACQUISITION; THERAPY;
D O I
10.1016/j.ijantimicag.2009.10.021
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Four Klebsiella pneumoniae isolates (KP1-4) were recovered sequentially from an infected patient. Whilst KP1-3 were resistant to all beta-lactams except carbapenems, KP4 recovered after 24 days of imipenem-containing treatment showed additional resistance to carbapenems. No carbapenem hydrolysis could be identified in KP4. Molecular characterisation revealed that KP1-4 were indistinguishable by pulsed-field gel electrophoresis, contained a 95-kb self-transferable plasmid harbouring bla(CTXM-15) and bla(TEM-1) genes and a 65-kb plasmid that was not transferred by conjugation into Escherichia coli, and harboured the plasmid-mediated bla(DHA-1) AmpC beta-lactamase gene. In addition, KP4 failed to express OmpK36 owing to a point mutation leading to a premature stop of the protein. This study demonstrates development of carbapenem resistance related to loss of OmpK36 expression in a K. pneumoniae isolate harbouring extended-spectrum beta-lactamase and plasmid-mediated cephalosporinase genes following prolonged imipenem exposure. (C) 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 15 条
  • [1] Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI
  • [2] Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece
    Cuzon, Gaelle
    Naas, Thierry
    Demachy, Marie Claude
    Nordmann, Patrice
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 796 - 797
  • [3] Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae:: review and bench guide
    Drieux, L.
    Brossier, F.
    Sougakoff, W.
    Jarlier, V.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 90 - 103
  • [4] In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase
    Elliott, E
    Brink, AJ
    van Greune, J
    Els, Z
    Woodford, N
    Turton, J
    Warner, M
    Livermore, DM
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) : E95 - E98
  • [5] SOLUBILIZATION OF CYTOPLASMIC MEMBRANE OF ESCHERICHIA-COLI BY IONIC DETERGENT SODIUM-LAURYL SARCOSINATE
    FILIP, C
    FLETCHER, G
    WULFF, JL
    EARHART, CF
    [J]. JOURNAL OF BACTERIOLOGY, 1973, 115 (03) : 717 - 722
  • [6] High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE
    Kaczmarek, Frank M.
    Dib-Hajj, Fadia
    Shang, Wenchi
    Gootz, Thomas D.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) : 3396 - 3406
  • [7] Collateral damage of flomoxef therapy:: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases
    Lee, Chen-Hsiang
    Chu, Chishih
    Liu, Jien-Wei
    Chen, Yi-Shung
    Chiu, Chiung-Jung
    Su, Lin-Hui
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 410 - 413
  • [8] In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae
    Lee, Chen-Hsiang
    Chia, Ju-Hsin
    Chu, Chishih
    Wu, Tsu-Lan
    Liu, Jien-Wei
    Su, Lin-Hui
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) : 857 - 860
  • [9] Extended-spectrum β-lactamases and the permeability barrier
    Martinez-Martinez, L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 82 - 89
  • [10] Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007
    Mata, C.
    Miro, E.
    Rivera, A.
    Mirelis, B.
    Coll, P.
    Navarro, F.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (05) : 473 - 476